Beacon Citations
Beacon citations are peer-reviewed scientific articles that reference the Beacon database.
Explore the publications below to see how researchers have used Beacon to inform their work, published in leading life science journals including Nature, Antibody Therapeutics, mAbs, and American Chemical Society.
Filter citations by your module of interest.
Filter by Module
- All
- ADC
- Autoimmune
- Bispecific
- Cancer Vaccine
- Cell Therapy
- Checkpoint
- CVRM
- Cytokine
- DDR
- Gene Therapy
- Microbiome
- Neurology
- Neuroscience
- Oncology
- Oncolytic Viruses
- Psychiatric
- RNA
- TPD
Gene Editing Strategies for Neurological and Mental Disorders: Advances in Delivery, Methodology, and Clinical Translation.
Cells
15
720
PMID: 42041587
mRNA vaccines and therapeutics beyond COVID-19: A review of the global clinical development landscape, low- and middle-income countries involvement and relevance to their contexts.
Hum Vaccin Immunother.
22
PMID: 41781347
The complexities of oligonucleotide therapeutics: analytical challenges and opportunities within early drug discovery.
Bioanalysis
17
1415
PMID: 41379075
Innovative antibody therapeutic development in China compared with the USA and Europe.
Nature Rev Drug Discov.
25
169
PMID: 41203983
Modular generation of multispecific antibodies using protein trans-splicing.
Mabs
17
PMID: 41104655
Navigating Solid Tumor Heterogeneity: The Promise and Challenges of Antibody-Drug Conjugates.
Pivot Science Publications
2
PMID: 41334034
Antibody-drug conjugates: Current challenges and innovative solutions for precision cancer therapy.
Med.
6
PMID: 41033317
Fundamental properties and principal areas of focus in antibody-drug conjugates formulation development.
Antib Thera.
8
99
PMID: 40177644
Present Scenario and Future Landscape of Payloads for ADCs: Focus on DNA-Interacting Agents.
Pharmaceuticals
7
1338
PMID: 39458979
Frameworks for transformational breakthroughs in RNA-based medicines.
Nature Rev Drug Discov.
23
421
PMID: 38740953
Breaking the mold with RNA—a “RNAissance” of life science.
NPJ Genom Med.
9
2
PMID: 38195675
The 17th EFMC Short Course on Medicinal Chemistry on Small Molecule Protein Degraders.
Chemistry Europe
18
PMID: 37817354
Proximity-Based Modalities for Biology and Medicine.
ACS Cent Sci.
9
1269
PMID: 37521793
Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors.
Mol Ther Oncolytics
19
78
PMID: 35434272
Enzymatic glycan remodeling–metal free click (GlycoConnect™) provides homogenous antibody-drug conjugates with improved stability and therapeutic index without sequence engineering.
Mabs
14
PMID: 35634725
Switchable assembly and function of antibody complexes in vivo using a small molecule.
Proc Natl Acad Sci U S A
119
PMID: 35210365
Novel development strategies and challenges for anti-Her2 antibody-drug conjugates.
Antib Thera.
5
18
PMID: 35146330
Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD).
Int J Mol Sci.
22
10594
PMID: 34638935
What makes a good antibody-drug conjugate?.
Expert Opin Biol Ther.
21
841
PMID: 33605810
1
2
Explore Our Latest Content
Search